Impaired proliferation and DNA synthesis of a human tumor cell line (HELA) caused by short treatment with the antianemic drug jectofer (ferric- sorbitol-citrate) and the lipid peroxidation product 4-hydroxynonenal

Cancer Biotherapy and Radiopharmaceuticals

Volumn 13, Issue 5, 1998, Pages 395-402

  Poljak Blazi, Marija ^a   Zarkovic, Neven ^a,b   Schaur, R Jorg ^b  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

4 Hydroxynonenal (HNE); Ferric sorbitol citrate (FSC); HeLa cell proliferation; Iron

Indexed keywords

4 HYDROXYNONENAL; IRON SORBITEX;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; DNA SYNTHESIS; DRUG ACTIVITY; DRUG EFFECT; GROWTH REGULATION; HELA CELL; HUMAN; HUMAN CELL; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0032438385     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1998.13.395     Document Type: Article

References (13)

1. Williams RJP. Haem-proteins and oxygen, in Jacobs, A, Worwood, M. (eds): Iron in Biochemistry and Medicine, London, UK, Academic Press, 1974, pp 183.
2. Tillian HM, Hammer A, Kink E, et al. Iron-induced lipid peroxidation and inhibition of proliferation of Ehrlich ascites tumour cells. J Cancer Res Clin Oncol 1989;115:79.
3. Floyd RA. Role of oxygen free radicals in cancerogenesis and brain ischemia. FASEB J 1998;4:2587.
4. Toyokuni S, Uchida K, Hattori-Nakakuki Y, et al. Formation of 4-hydroxy-2-none-nal-modified proteins in renal proximal tubules of rats treated with renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci USA 1994;91:2616.
5. Esterbauer H, Schaur RJ Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81.
6. 16 growth. Period Biol 1985;87:17.
7. Flajsig I, Poljak-Blazi M. Influence of iron on proliferation and cell cycle kinetics on cultured malignant and nonmalignant cells. Oncology 1990;47:443.
8. Schauenstein E, Esterbauer H, Zollner H. Aldehydes in biological systems; their natural occurrence and biological activities. Pion Ltd, London, 1977.
9. Schaur R J, Zollner H, Esterbauer H. Biological effects of aldehydes with particular attention to 4-hydroxynonenal and malonaldehyde. In: Membrane lipid oxidation, Vol. III. (Vigo-Pelfrey C, ed) CRC Press, Inc: Boca Raton, Florida, 1991; pp 141-163.
10. Esterbauer H, Zollner H, Schaur RJ. Aldehydes formed by lipid peroxidation: mechanisms of formation, occurrence, and determination. In: Membrane Lipid Oxidation, Vol. I (Vigo-Pelfrey C, ed) CRC Press, Inc: Boca Raton, Florida, 1990, pp 239-268.
11. Strohmaier H, Hinghofer-Szalkay H, Schaur RJ. Detection of 4-hydroxynonenal (HNE) as a physiological component in human plasma. J Lipid Mediators Cell Signalling 1995;11:51.
12. Zarkovic N, Ilic Z, Jurin M, Schaur RJ, Puhl H, Esterbauer H. Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochemistry and Function 1993;11:279.
13. Zarkovic N, Tillian MH, Schaur RJ, Waeg G, Jurin M, Esterbauer H. Inhibition of melanoma B16-F10 growth by lipid peroxidation product 4-hydoxynonenal. Cancer Biotherapy 1995;10:153.